These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37678380)

  • 1. Identification and detection of microRNA kidney disease biomarkers in liquid biopsies.
    Smith DA; Redman JE; Fraser DJ; Bowen T
    Curr Opin Nephrol Hypertens; 2023 Nov; 32(6):515-521. PubMed ID: 37678380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiRNAs as potential biomarker of kidney diseases: A review.
    Ramanathan K; Padmanabhan G
    Cell Biochem Funct; 2020 Dec; 38(8):990-1005. PubMed ID: 32500596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of microRNAs in renal disorders related to primary podocyte dysfunction.
    Iranzad R; Motavalli R; Ghassabi A; Pourakbari R; Etemadi J; Yousefi M
    Life Sci; 2021 Jul; 277():119463. PubMed ID: 33862110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in Diabetic Nephropathy: From Biomarkers to Therapy.
    Simpson K; Wonnacott A; Fraser DJ; Bowen T
    Curr Diab Rep; 2016 Mar; 16(3):35. PubMed ID: 26973290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA Expression Profiling in Diabetic Kidney Disease.
    Ishii H; Kaneko S; Yanai K; Aomatsu A; Hirai K; Ookawara S; Morishita Y
    Transl Res; 2021 Nov; 237():31-52. PubMed ID: 34102327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs in kidney physiology and disease.
    Trionfini P; Benigni A; Remuzzi G
    Nat Rev Nephrol; 2015 Jan; 11(1):23-33. PubMed ID: 25385286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA biomarkers in clinical renal disease: from diabetic nephropathy renal transplantation and beyond.
    Nassirpour R; Raj D; Townsend R; Argyropoulos C
    Food Chem Toxicol; 2016 Dec; 98(Pt A):73-88. PubMed ID: 26925770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. microRNAs in Diabetic Kidney Disease.
    Chung AC
    Adv Exp Med Biol; 2015; 888():253-69. PubMed ID: 26663187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA expression signatures and posttranscriptional regulation in diabetic nephropathy.
    Rudnicki M; Beckers A; Neuwirt H; Vandesompele J
    Nephrol Dial Transplant; 2015 Aug; 30 Suppl 4():iv35-42. PubMed ID: 26209736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating MicroRNAs as Cancer Biomarkers in Liquid Biopsies.
    Suárez B; Solé C; Márquez M; Nanetti F; Lawrie CH
    Adv Exp Med Biol; 2022; 1385():23-73. PubMed ID: 36352210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel targets of diabetic nephropathy and PEDF peptide treatment using RNA-seq.
    Rubin A; Salzberg AC; Imamura Y; Grivitishvilli A; Tombran-Tink J
    BMC Genomics; 2016 Nov; 17(1):936. PubMed ID: 27855634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs and drug-induced kidney injury.
    Pavkovic M; Vaidya VS
    Pharmacol Ther; 2016 Jul; 163():48-57. PubMed ID: 27126472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging roles for miRNAs in the development, diagnosis, and treatment of diabetic nephropathy.
    DiStefano JK; Taila M; Alvarez ML
    Curr Diab Rep; 2013 Aug; 13(4):582-91. PubMed ID: 23666892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Where are we in diabetic nephropathy: microRNAs and biomarkers?
    McClelland A; Hagiwara S; Kantharidis P
    Curr Opin Nephrol Hypertens; 2014 Jan; 23(1):80-6. PubMed ID: 24247820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary miRNA-27b-3p and miRNA-1228-3p correlate with the progression of Kidney Fibrosis in Diabetic Nephropathy.
    Conserva F; Barozzino M; Pesce F; Divella C; Oranger A; Papale M; Sallustio F; Simone S; Laviola L; Giorgino F; Gallone A; Pontrelli P; Gesualdo L
    Sci Rep; 2019 Aug; 9(1):11357. PubMed ID: 31388051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urine miRNAs: potential biomarkers for monitoring progression of early stages of diabetic nephropathy.
    Yang Y; Xiao L; Li J; Kanwar YS; Liu F; Sun L
    Med Hypotheses; 2013 Aug; 81(2):274-8. PubMed ID: 23683774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
    Eissa S; Matboli M; Bekhet MM
    Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid Biopsy: A New Avenue for the Diagnosis of Kidney Disease: Diabetic Kidney Disease, Renal Cancer, and IgA Nephropathy.
    Dybiec J; Frąk W; Kućmierz J; Tokarek J; Wojtasińska A; Młynarska E; Rysz J; Franczyk B
    Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38254967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs and diabetic kidney disease: Systematic review and bioinformatic analysis.
    Assmann TS; Recamonde-Mendoza M; de Souza BM; Bauer AC; Crispim D
    Mol Cell Endocrinol; 2018 Dec; 477():90-102. PubMed ID: 29902497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of non-coding RNAs in diabetic nephropathy: potential applications as biomarkers for disease development and progression.
    Alvarez ML; Distefano JK
    Diabetes Res Clin Pract; 2013 Jan; 99(1):1-11. PubMed ID: 23102915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.